Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effect of Galactose on Permeblity Factor in Patients With FSGS and CKD Stage 5

This study has suspended participant recruitment.
(Under additional IRB Review)
Sponsor:
Collaborator:
Medical College of Wisconsin
Information provided by:
North Shore Long Island Jewish Health System
ClinicalTrials.gov Identifier:
NCT00816504
First received: December 31, 2008
Last updated: September 9, 2009
Last verified: September 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: December 2009
  Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)